![]() |
|
|
Vol. 30, Issue 11, 1170-1179, November 2002
Section of Developmental Pharmacology and Experimental
Therapeutics, Division of Pediatric Clinical Pharmacology and Medical
Toxicology, Children's Mercy Hospitals and Clinics (R.E.P., J.S.L.),
and Departments of Pediatrics (J.S.L.), Pharmacology (J.S.L.), and
Pharmaceutical Sciences (G.R.V.), University of Missouri-Kansas City,
Kansas City, Missouri
In vitro studies were conducted to identify the cytochromes P450
(P450s) involved in the formation of 2- and
3-hydroxycarbamazepine, metabolites that may serve as precursors in the
formation of protein-reactive metabolites. Human liver microsomes
(HLMs) converted carbamazepine (30-300 µM) to 3-hydroxycarbamazepine
at rates >25 times those of 2-hydroxycarbamazepine. Both the 2- and
3-hydroxylation of carbamazepine appeared to conform to monophasic
Michaelis-Menten kinetics in HLMs (apparent
Km values, ~1640 and ~217 µM; apparent Vmax values, ~5.71 and ~46.9 pmol/mg of
protein/min, respectively). Rates of carbamazepine 2- and
3-hydroxylation correlated strongly with CYP2B6 activity
(r
0.757) in a panel of HLMs
(n = 8). Carbamazepine 3-hydroxylation also
correlated significantly with CYP2C8 activity at a carbamazepine
concentration of 30 µM. Formation of 2- and 3-hydroxycarbamazepine
did not correlate significantly with any other P450 activities. The
chemical inhibitors ketoconazole (CYP3A) and 7-EFC (CYP2B6) inhibited
both 2- and 3-hydroxycarbamazepine formation whereas 4-methylpyrazole
(CYP2E1) markedly decreased 2-hydroxycarbamazepine formation. Several
recombinant P450s catalyzed carbamazepine 2- and 3-hydroxylation, but
after adjustment for relative hepatic abundance, CYP3A4 and CYP2B6
appeared to be the major catalysts of carbamazepine 3-hydroxylase
activity, and at least five P450s were significant contributors to
2-hydroxycarbamazepine formation; CYP2E1 made the greatest contribution
to the Clint of carbamazepine 2-hydroxylation (~30%),
but P450s CYP1A2, 2A6, 2B6, and 3A4 also made significant contributions
(~13-18%). These results suggest that CYP2B6 and CYP3A4 are largely
responsible for the formation of 3-hyrdoxycarbamazepine, whereas
multiple P450s (CYP1A2, 2A6, 2B6, 2E1, and 3A4) contributed to
2-hydroxycarbamazepine formation.
This article has been cited by other articles:
![]() |
R. E. Pearce, W. Lu, Y. Wang, J. P. Uetrecht, M. A. Correia, and J. S. Leeder Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine Drug Metab. Dispos., August 1, 2008; 36(8): 1637 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kang, M. Liao, M. R. Wester, J. S. Leeder, R. E. Pearce, and M. A. Correia CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile Drug Metab. Dispos., March 1, 2008; 36(3): 490 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Faucette, T.-C. Zhang, R. Moore, T. Sueyoshi, C. J. Omiecinski, E. L. LeCluyse, M. Negishi, and H. Wang Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 72 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Pearce, J. P. Uetrecht, and J. S. Leeder PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE Drug Metab. Dispos., December 1, 2005; 33(12): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Sandson, S. C. Armstrong, and K. L. Cozza An Overview of Psychotropic Drug-Drug Interactions Psychosomatics, October 1, 2005; 46(5): 464 - 494. [Abstract] [Full Text] [PDF] |
||||